一个心力衰竭网络模型,以改善结果和跨部门指导方针的医疗治疗利用率
Christina Paitazoglou1,2, Dominik Jurczyk1,2, Matthias Mezger1,2
1University Heart Center Lübeck, Medical Clinic II (Cardiology, Angiology, Intensive Care Medicine), University Hospital Schleswig-Holstein (UKSH) - Campus Lübeck, Lübeck, Germany.
ESC heart failure
|October 10, 2025
概括
在德国北部实施多部门心力衰竭 (HF) 网络增加了门诊治疗和转诊. 早期趋势表明,可以改善高频率管理和减少疾病负担,尽管再住院和死亡率需要进一步监测.
科学领域:
- 心脏病学 心脏病学
- 公共卫生 公共卫生
- 医疗保健管理的管理
背景情况:
- 心力衰竭 (HF) 在全球范围内对住院,死亡率和医疗保健费用做出了重大贡献.
- 有效的查和对HF患者的管理对于降低其社会经济负担至关重要.
- 高频网络是优化患者护理途径的推策略.
研究的目的:
- 在德国北部开发和实施一个多部门心力衰竭 (HF) 网络.
- 分析患者的发展轨迹,并确定需要改善的HF护理领域.
- 评估HF网络对患者结果和疾病负担的影响.
主要方法:
- 将12个地方高频网络整合到全州,多部门网络中.
- 分析了实施前 (2018-2020) 和实施后 (2021-2023) 期间的住院和门诊数据集.
- 检查了患者轨迹,转诊模式,治疗活动,再住院率和死亡率.
主要成果:
- 实施后,门诊治疗病例增加了101.3% (P < 0.001) 和专家推增加了49.7% (P = 0.013).
- 住院患者入院率上升了20.7% (P = 0.03),而全科医生转诊率则显示出非显著的增加.
- 肺炎再住院率 (17.9%对20.3%) 和住院死亡率 (10.2%对8.8%) 没有显著变化.
结论:
- 多部门的高频网络促进了对患者护理途径的分析,并确定了改进领域.
- 观察到的门诊治疗和转诊的增加表明,HF管理的早期趋势是积极的.
- 该网络显示了提高HF护理和减轻国家HF负担的潜力.
更多相关视频
相关概念视频
01:30Heart Failure V: Medical Management
218
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
218
01:30Heart Failure VII: Nursing Interventions
416
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
416
01:29Cardiomyopathy V: Interprofessional Care
338
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
338
01:22Heart Failure VI: Adjunct Therapies
255
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
255
01:30Heart Failure IV: Classification and Diagnostic Evaluation
319
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
319
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
932
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
932